Welcome to our dedicated page for Datametrex Ai Li news (Ticker: DTMXF), a resource for investors and traders seeking the latest updates and insights on Datametrex Ai Li stock.
The Datametrex AI Limited (DTMXF) news page on Stock Titan aggregates company announcements and updates related to its activities in Technology Solutions, Artificial Intelligence, fintech payments, and healthcare. Datametrex regularly issues news releases covering its subsidiaries, new contracts, acquisitions, and operational developments.
Investors and followers can review updates on Datametrex Korea, the company’s wholly owned subsidiary that secures IT infrastructure and technology solutions purchase orders from large global enterprises. These items often highlight new purchase orders, revenue expectations tied to those orders, and commentary on the company’s "land and expand" approach with global partners.
The news feed also features developments from Paymetrex Payment Solutions Inc., another wholly owned subsidiary focused on payment technologies. Recent releases describe a Technology Licensing Agreement with AnywhereCommerce Inc., plans to market payment solutions under the YuzuPay brand, and the acquisition of the Yuzu Payment Solution from Firstpayment Inc., including related patents and intellectual property.
Healthcare-related news appears through Imagine Health Medical Clinics Ltd., Datametrex’s wholly owned healthcare subsidiary. Announcements include clinic relocations in Calgary and Edmonton, the opening of new facilities, the launch of walk-in services for urgent, non-emergency care, and the addition of new physicians to expand capacity for family medicine and specialized medical services.
By following this page, readers can access a chronological record of Datametrex’s disclosed activities across technology, payments, and healthcare. The coverage includes corporate strategy updates, subsidiary milestones, and participation in capital markets events, helping users understand how the company presents its progress and business initiatives over time.
Datametrex (OTC:DTMXF) received a $500,000 purchase order on February 6, 2026 from a Fortune 500 client in South Korea for data centre operations and infrastructure solutions. The order carries an estimated profit margin of ~20% and supports commercialization of the company's HCI-based private cloud and managed services platform.
The engagement highlights demand for AI-enabled infrastructure, GPU optimization, and scalable managed services while reinforcing Datametrex Korea's role in delivery and the company’s focus on recurring revenue growth through integrated infrastructure solutions.
Datametrex (OTC:DTMXF) announced Paymetrex launched a U.S. patent licensing program and signed a first non-exclusive license dated February 6, 2026.
Under the agreement Paymetrex will receive US$400,000 annually for the remaining life of the applicable patents. The portfolio lists nine U.S. and two Canadian patents and the company plans AI-driven licensing and portfolio expansion.
Datametrex (OTC:DTMXF) is expanding into modern data centre operations and infrastructure solutions, deploying Nutanix-based hyperconverged infrastructure (HCI) to unify servers, storage and networking.
The company reports successful deployments in South Korea, plans North American rollouts, and offers end-to-end services under an HCI SaaS model that aims to generate recurring revenue via long-term service and maintenance contracts. Datametrex also highlights AI-driven features such as load sharing and GPU optimization and is exploring data management with proprietary AI and third-party quantum servers.
Datametrex (OTC:DTMXF) subsidiary Paymetrex launched a patent licensing program to monetize its mobile payments IP portfolio, which includes nine issued U.S. and Canadian patents filed as early as 2011.
Paymetrex says portions of the portfolio are already licensed; the program targets payment processors, fintechs, merchants and infrastructure providers operating in large, fast-growing mobile wallet markets.
Datametrex AI (OTC:DTMXF) will participate in the AlphaNorth Capital Event hosted by CEM from January 16–18, 2026. The event schedules one-on-one meetings for growth-stage companies in Resource, Technology, Biotech, and Special Situations sectors to meet capital markets participants and professional investors. Datametrex said it will discuss its progress, strategy, and growth initiatives with existing and prospective investors. Event details are available on the conference website and participation runs across the full day of scheduled meetings.
Datametrex (OTC:DTMXF) announced that its Korea subsidiary secured new purchase orders with a combined value of approximately CAD $400,000 on January 8, 2026. The orders are expected to generate about CAD $400,000 in revenue with an estimated profit margin of 17.5%. The company said the contracts support its global growth strategy and "land and expand" approach, reinforcing Datametrex's role as a provider of IT infrastructure and technology solutions to large global enterprises.
Management highlighted continued demand from enterprise partners and noted the Korean subsidiary as a key contributor to revenue growth.
Datametrex (OTC:DTMXF) subsidiary Paymetrex entered a Technology Licensing Agreement dated December 17, 2025 with AnywhereCommerce to access its payment products and services.
Paymetrex will combine AnywhereCommerce technology with its proprietary IP, market payment solutions under the YuzuPay brand via direct sales, ISVs and ISOs, and appoint resellers across luxury merchant categories. Paymetrex holds a 10‑patent granted portfolio and plans to file at least one provisional patent for quantum‑enhanced payment security.
The release cites AnywhereCommerce's deployment of 20 million devices across 15 countries and a Grand View Research crypto payments market projection from USD 556.9M (2024) to USD 2.4B (2033) at a 17.8% CAGR.
Datametrex (OTC:DTMXF) completed the acquisition of the Yuzu payment processing solution from Firstpayment via subsidiary Paymetrex on December 19, 2025. The purchase price was $5.5 million, satisfied by issuance of 55,000,000 common shares at a deemed price of $0.10 per share, subject to a four-month-and-one-day hold period.
The company did not assume Firstpayment debt. Proceeds from a prior private placement were released from escrow to fund integration of Yuzu and merchant commercialization efforts. Michael Kron was appointed to the board and now holds approximately 12.15% of outstanding common shares.
Datametrex (OTC:DTMXF) signed a definitive asset purchase agreement dated December 9, 2025 to acquire the Yuzu payment processing solution, including related patents and intellectual property, from Firstpayment for a purchase price of $5.5 million.
The purchase price will be satisfied by issuing 55,000,000 common shares at a deemed price of $0.10 per share to Firstpayment. Completion is expected on or about December 17, 2025, subject to customary closing conditions and TSXV approval.
Upon closing, proceeds from a previously announced private placement will be released from escrow to integrate Yuzu into Datametrex's technology division and pursue merchant revenue opportunities; Michael Kron is expected to join the board and serve as COO of Paymetrex.
Datametrex (OTC:DTMXF) announced on December 1, 2025 that its wholly owned subsidiary Imagine Health has launched walk-in services at Calgary and Edmonton clinics, and is accepting new family patients.
Both clinics operate Monday to Friday, 8:30 AM–4:30 PM, and will treat same-day, non-emergency needs including respiratory infections, minor injuries, urgent prescriptions, and chronic condition flare-ups. Locations, phone numbers, and clinic hours are provided for patient access.
The company said the expansion advances its goal of improving timely, patient-focused care across Western Canada and signals continued exploration of broader clinic network growth.